
No significant difference in the incidence of VTE between IV TXA and control in orthopaedic surgery

No significant difference in the incidence of VTE between IV TXA and control in orthopaedic surgery
Safety of intravenous tranexamic acid in patients undergoing major orthopaedic surgery: a meta-analysis of randomised controlled trials
Blood Transfus. 2018 Jan;16(1):36-43Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
73 randomized controlled trials were included in this meta-analysis investigating the incidence of venous thromboembolic complications between patients administered intravenous tranexamic acid and patients who were not administered TXA. Meta-analysis demonstrated no significant difference between IV TXA groups and control groups in the incidence of VTE complications, which were estimated at 2.1% a...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.